SculpSure
SculpSure is a Cynosure Lutronic-owned, FDA-cleared non-invasive diode laser body contouring brand, sold B2B to dermatologists, plastic surgeons, and aesthetic clinics via a global certified-provider network.
- Company typePrivate
- Founded-
- HeadquartersSanford, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What SculpSure does
SculpSure is a non-invasive laser body contouring product brand owned by Cynosure, which now operates as Cynosure Lutronic following its merger with Lutronic. The platform uses 1060 nm diode laser technology to deliver controlled thermal energy to subcutaneous adipose tissue, disrupting fat cells without surgery or downtime; the core SculpSure® system is positioned around a 25-minute treatment cycle capable of treating multiple body areas in a single session. A dedicated variant, SculpSure® – Submental, targets submental fat under the chin and jawline, extending the indication set beyond the core body-contouring use case. The technology is FDA-cleared for non-invasive lipolysis, a regulatory credential that anchors marketing claims and provider purchasing decisions.\n\nThe business model is B2B capital equipment sales to clinical practices — dermatologists, plastic surgeons, and medical aesthetic clinics — who in turn deliver SculpSure treatments to patients on a per-procedure fee basis. Revenue mechanics combine an upfront device sale with a recurring consumables stream accessed through Cynosure's provider webstore, supplemented by the AMPS (Aesthetic Marketing & Practice Support) program that supplies practice-level marketing and operational resources to installed-base providers. Distribution is governed by Cynosure's certified-provider model, and the brand is actively positioned across North America (US, Canada), Europe (UK, Germany, Spain, France, Portugal), Asia-Pacific (Australia, Japan, Korea), and the Middle East.\n\nSculpSure does not operate as a standalone corporate entity; it is a product line within Cynosure Lutronic, with headquarters effectively co-located with the parent in Westford, Massachusetts. As a result, standalone financials, a dedicated executive team, and product-line-specific operating metrics are not publicly disclosed, and any investment thesis must be framed in the context of the parent's portfolio economics rather than the brand in isolation.
SculpSure firmographics
Firmographics- Name
- SculpSure
- Legal name
- SculpSure (no standalone legal name found - appears as Cynosure product brand)
- Website
- https://sculpsure.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SculpSure is a Cynosure Lutronic-owned, FDA-cleared non-invasive diode laser body contouring brand, sold B2B to dermatologists, plastic surgeons, and aesthetic clinics via a global certified-provider network.
- Ownership category
- akta.pro rank
SculpSure industry classification
Industry- Product category
- Medical Aesthetic Devices
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Body Contouring & Non-Invasive Aesthetic Recovery (e.g., Lymphatic Drainage) (HSADAKAM)
Keywords
Where SculpSure is headquartered
LocationHeadquarters
- HQ city
- Sanford
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SculpSure business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Marketing or Sales, Personnel, Supply Chain
Revenue model
- Medical Device Sales: SculpSure is sold as a medical aesthetic device to certified providers and clinics. Revenue is generated through device sales to medical practitioners who offer body contouring treatments to patients.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
SculpSure product offering
Product offeringCore offering
SculpSure is a non-invasive laser body contouring medical device that reduces stubborn fat in 25 minutes without surgery. The system uses laser-based energy to deliver FDA-cleared non-invasive lipolysis treatments for body contouring, including a submental variant for fat reduction under the chin. Devices are sold to certified medical aesthetic providers who offer treatments to patients.
Product overview
SculpSure is a non-invasive body contouring technology brand under Cynosure Lutronic. The core SculpSure® system uses laser technology for body fat reduction, while the SculpSure® – Submental variant targets fat reduction specifically under the chin. Cynosure's broader portfolio includes multiple aesthetic laser and energy-based devices including XERF™, Ultra, Clarity II, Genius, Mosaic 3D, DermaV, and PicoSure® Pro, offering treatments ranging from skin rejuvenation to hair removal and body contouring.
Differentiator
Problem solved
Functional benefit
Products and services
- SculpSure®
Companies that use SculpSure
Customer profileSegments2 records
Ideal customer profiles1 record
SculpSure technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
SculpSure partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- Cynosure Certified ProviderscoreCynosure partners with a network of certified medical aesthetic providers including dermatologists, plastic surgeons, and aesthetic clinics who purchase and operate SculpSure devices to offer treatments to patients. Providers undergo certification and training to offer Cynosure treatments.
- LutronicflagshipCynosure merged with Lutronic, combining two major players in the medical aesthetic device industry. The combined company operates under Cynosure Lutronic branding and offers an integrated portfolio including SculpSure, PicSure, and other aesthetic devices.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
SculpSure competitors and assessment
Company assessmentBroad incumbents
- Cutera: Public medical aesthetic device company offering a portfolio of laser, RF, and body contouring systems (including truSculpt) sold to dermatologists, plastic surgeons, and medical spas. Competes broadly in the same channel as SculpSure's distributor.
- Lumenis (Boston Scientific): Global aesthetic and surgical laser company now part of Boston Scientific, offering energy-based devices across aesthetic and clinical specialties. Competes broadly with Cynosure's portfolio, including in body contouring-adjacent indications.
- Alma Lasers (Sisram Medical): Global medical aesthetic device company with a broad energy-based portfolio including body contouring, hair removal, skin rejuvenation, and women's wellness products. Sells through a similar certified provider network across multiple geographies.
- Sciton: Privately held US medical aesthetic device manufacturer with a broad laser and light-based platform sold to dermatologists and plastic surgeons. Operates in overlapping provider channels and competes for practice-level capital budgets.
- Cynosure Lutronic: Parent entity and broader aesthetic device portfolio company that owns and distributes SculpSure. Operates multiple laser, RF, and energy-based platforms across body contouring, skin rejuvenation, hair removal, and women's health.
Direct peers
- CoolSculpting (AbbVie / Allergan Aesthetics): The market-leading non-invasive fat reduction device using cryolipolysis, sold through a certified provider network. Directly competes with SculpSure in the same body contouring category with similar practice economics and patient demographic.
- truSculpt (Cutera): RF-based non-invasive body contouring system sold to aesthetic practices. Competes with SculpSure in fat reduction with comparable treatment positioning and provider-targeted sales model.
- UltraShape (Candela / Syneron Medical): Ultrasound-based non-invasive fat destruction device marketed to aesthetic practitioners. Competes with SculpSure as an alternative non-invasive modality for body contouring.
- Vanquish (BTL Aesthetics): Contactless RF device for non-invasive fat reduction sold to medical aesthetic providers. Directly competes with SculpSure for non-invasive body contouring indications.
- Emsculpt (BTL Aesthetics): Non-invasive body contouring device using HIFEM technology to reduce fat and build muscle. Sold through medical aesthetic providers and directly competes with SculpSure for clinic capital budgets and patient consultations.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
SculpSure social profiles
Digital presenceSculpSure financial estimates
Financial estimateRevenue estimate
Valuation estimate
SculpSure leadership team
Management profileNumber of profiles
SculpSure funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SculpSure M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SculpSure
What does SculpSure do?
SculpSure is a non-invasive laser body contouring medical device that reduces stubborn fat in 25 minutes without surgery. The system uses laser-based energy to deliver FDA-cleared non-invasive lipolysis treatments for body contouring, including a submental variant for fat reduction under the chin. Devices are sold to certified medical aesthetic providers who offer treatments to patients.
Is SculpSure a public or private company?
SculpSure is a private company. It is classified as corporate owned and is currently operating.
When was SculpSure founded?
SculpSure was founded in -1. It employs 51 to 100 people.
Where is SculpSure based?
SculpSure is headquartered in Sanford, United States, in the North America region.
How does SculpSure make money?
One revenue line is on record: medical Device Sales.
Who are SculpSure's main competitors?
Broad incumbents on record are Cutera, Lumenis (Boston Scientific), Alma Lasers (Sisram Medical), Sciton and Cynosure Lutronic. Direct peers are CoolSculpting (AbbVie / Allergan Aesthetics), truSculpt (Cutera), UltraShape (Candela / Syneron Medical), Vanquish (BTL Aesthetics) and Emsculpt (BTL Aesthetics).
Does SculpSure have an API?
No public API is recorded for SculpSure.
What industry is SculpSure in?
SculpSure's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HSADAKAM, Body Contouring & Non-Invasive Aesthetic Recovery (e.g., Lymphatic Drainage). Its SIC code is 3841.